ISSN : 2348 - 8948

Current Issue

Volume : 6 Issue :3 Month : March (2018)
Page Numbers : 400-405

In vivo Evaluation of Antiproliferative Activity of a Novel Benzimidazole Derivative Against Daltons Lymphoma Ascitic in Swiss Albino Mice

P. T. Manju*, A. Anton Smith, V. Padmaja
The present work was to evaluate the antiproliferative activity of a novel benzimidazole derivative, [N-[3-chloro-2-oxo-4-(2-hydroxyphenyl)-4-oxoazetidin-1yl]-2-(2-methyl-1H-benzimidazol-1-yl)acetamide] against tumour induced in female Swiss albino mice. The effective dose of the test compound was determined as 10 mg/kg body weight. Two doses of the test compound were used for the evaluation. 5- Fluorouracil at a dose of 20 mg/kg body weight was used as the standard. Derived, haemotological and biochemical parameters were evaluated. RBC, Hb level, platelet count and packed cell volume that reduced significantly in cancer control group became normal after treatment with test drug. WBC count that increased significantly in DAL control group became normal by treatment with test drug. The results strongly support the anti-proliferative activity of novel benzimidazole derivative [N-[3-chloro-2-oxo-4-(2-hydroxyphenyl)-4-oxoazetidin-1yl]-2-(2-methyl-1H-benzimidazol-1-yl)acetamide] against cancer induced female Swiss albino mice.
 
Full Text Attachment
No.Of Views : (90) Downloads : (4)
Tell a Friend

 

© 2013 Ijpda , all rights reserved. || Designed by The Colour Moon || Visit Counter